Bio shares rose sharply after announcing upcoming presentations on its obesity treatment candidate at two industry ...
TipRanks on MSN
iBio Regains Nasdaq Compliance with Bid Price Rule
On November 4, 2025, iBio, Inc. announced that it has regained compliance with the Nasdaq Listing Rule 5550(a)(2), which requires a minimum closing bid price of $1.00 per share. This follows a ...
Hosted on MSN
iBio announces offering of common stock, warrants
iBio (IBIO) announced it has commenced an underwritten public offering of (i) pre-funded warrants to purchase shares of iBio’s common stock, and (ii) accompanying Series G warrants each representing ...
We recently published a list of 10 Stocks Insiders Are Buying This Year. In this article, we are going to take a look at where Ibio, Inc. (NYSEAMERICAN:IBIO) stands against other stocks that insiders ...
Felipe Duran, the Chief Financial Officer of $IBIO ($IBIO), bought 9,191 shares of the company on 01-10-2025. This trade was reported by Quiver Quantitative using ...
SAN DIEGO, Feb. 19, 2025 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO), an AI-driven innovator of precision antibody therapies, today announced that iBio’s common stock has been approved for listing on ...
We recently published a list of 20 Stocks Insiders Were Buying In Q1 2025. In this article, we are going to take a look at where iBio, Inc. Common Stock (NASDAQ:IBIO) stands against other stocks ...
On Thursday, iBio, Inc. (NYSE:IBIO) expanded its cardiometabolic and obesity treatment development program by in-licensing a potentially long-acting anti-myostatin antibody from AstralBio, Inc. In ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback